Skip to main content

Motus GI Holdings, Inc. (MOTS)

NASDAQ: MOTS · Delayed Price · USD
0.718
+0.000 (0.01%)
Pre-market:Sep 23, 2021 4:00 AM EDT
0.717
0.012 (1.72%)
At close: Sep 22, 4:00 PM
Market Cap34.61M
Revenue (ttm)220,000
Net Income (ttm)-23.87M
Shares Out47.73M
EPS (ttm)-0.59
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume157,997
Open0.705
Previous Close0.705
Day's Range0.703 - 0.722
52-Week Range0.674 - 2.740
Beta2.58
AnalystsBuy
Price Target2.03 (+183.0%)
Est. Earnings DateNov 11, 2021

About MOTS

Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

IndustryHealth Care Equipment & Supplies
IPO DateFeb 14, 2018
CEOTimothy Moran
Employees24
Stock ExchangeNASDAQ
Ticker SymbolMOTS
Full Company Profile

Financial Performance

In 2020, MOTS's revenue was $98,000, a decrease of -8.41% compared to the previous year's $107,000. Losses were -$19.26 million, -16.59% less than in 2019.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 2.03, which is an increase of 182.97% from the latest price.

Price Target
$2.03
(182.97% upside)
Analyst Consensus: Buy

News

Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System

FORT LAUDERDALE, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

2 weeks ago - GlobeNewsWire

Motus GI Holdings, Inc. (MOTS) Reports Q2 Loss, Tops Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.09% and 20.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Motus GI to Release Second Quarter Results and Provide a Business Update on August 12

FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

1 month ago - GlobeNewsWire

Motus GI to Present at the Ladenburg Thalmann Healthcare Conference

FORT LAUDERDALE, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...

2 months ago - GlobeNewsWire

Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Au...

FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

2 months ago - GlobeNewsWire

Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology

FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

3 months ago - GlobeNewsWire

Motus GI's Pure-Vu System® Adopted by Sinai Hospital of Baltimore

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of ...

3 months ago - GlobeNewsWire

7 Cheap Stocks to Buy Now Under $3

It can be difficult to find cheap stocks worth buying. But these seven companies look promising and are all under $3.

Other symbols:BHATBIOLCTRMAUMNWTRH
4 months ago - InvestorPlace

Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Tops Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -10.00% and 27.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Recap: Motus GI Hldgs Q1 Earnings

Shares of Motus GI Hldgs (NASDAQ:MOTS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 52.17% year over year to ($0.11), which missed t...

4 months ago - Benzinga

Motus GI Reports First Quarter 2021 Financial Results and Provides Corporate Update

FORT LAUDERDALE, Fla., May 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cli...

4 months ago - GlobeNewsWire

Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness ...

- - - - The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveil...

4 months ago - GlobeNewsWire

Motus GI Holdings, Inc. (MOTS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

MOTS Stock: The Big FDA News That Has Motus GI Holdings Soaring Today

Motus GI Holdings (MOTS) stock is on the rise Friday following clearance from the FDA for one of the company's medical devices. The post MOTS Stock: The Big FDA News That Has Motus GI Holdings Soaring T...

4 months ago - InvestorPlace

Penny Stocks to Buy? Check These Tech Stocks Out

Tech penny stocks are back in focus; check these 3 out The post Penny Stocks to Buy? Check These Tech Stocks Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CCONOK
4 months ago - PennyStocks

Motus GI Receives FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy

FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

4 months ago - GlobeNewsWire

Motus GI to Release First Quarter Results and Provide a Business Update on May 13

FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

4 months ago - GlobeNewsWire

Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy

Motus GI Holdings Inc (NASDAQ: MOTS) has submitted a 510(k) application to the FDA for a version of the Pure-Vu System. The new version of the system is compatible with gastroscopes used during upper ga...

5 months ago - Benzinga

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0.00% and -61.29%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

FORT LAUDERDALE, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

6 months ago - GlobeNewsWire

Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleed...

FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

6 months ago - GlobeNewsWire

Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16

FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

6 months ago - GlobeNewsWire

Motus GI to Participate in Two Upcoming Investor Conferences in March 2021

FORT LAUDERDALE, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve c...

6 months ago - GlobeNewsWire

Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million

FORT LAUDERDALE, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...

7 months ago - GlobeNewsWire